On Friday, Bioventus Inc (NASDAQ: BVS) was 10.87% up from the session before settling in for the closing price of $6.53. A 52-week range for BVS has been $5.81 – $12.61.
A company in the Healthcare sector has dropped its sales by -113.92% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 9.14%. With a float of $46.02 million, this company’s outstanding shares have now reached $66.97 million.
Bioventus Inc (BVS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Bioventus Inc stocks. The insider ownership of Bioventus Inc is 31.30%, while institutional ownership is 54.17%. The most recent insider transaction that took place on Nov 07 ’25, was worth 131,255. In this transaction Director of this company sold 17,701 shares at a rate of $7.42, taking the stock ownership to the 56,997 shares. Before that another transaction happened on Nov 07 ’25, when Company’s Director proposed sale 27,000 for $7.41, making the entire transaction worth $200,041.
Bioventus Inc (BVS) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.15 earnings per share (EPS) during the time that was better than consensus figure (set at 0.08) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.47% during the next five years compared to -113.92% drop over the previous five years of trading.
Bioventus Inc (NASDAQ: BVS) Trading Performance Indicators
You can see what Bioventus Inc (BVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.06. Likewise, its price to free cash flow for the trailing twelve months is 11.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.11, a number that is poised to hit 0.20 in the next quarter and is forecasted to reach 0.72 in one year’s time.
Technical Analysis of Bioventus Inc (BVS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.33 million. That was inferior than the volume of 0.38 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.75%.
During the past 100 days, Bioventus Inc’s (BVS) raw stochastic average was set at 58.37%, which indicates a significant increase from 43.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.41 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.95, while its 200-day Moving Average is $7.52. However, in the short run, Bioventus Inc’s stock first resistance to watch stands at $7.52. Second resistance stands at $7.79. The third major resistance level sits at $8.32. If the price goes on to break the first support level at $6.72, it is likely to go to the next support level at $6.19. The third support level lies at $5.92 if the price breaches the second support level.
Bioventus Inc (NASDAQ: BVS) Key Stats
There are 82,763K outstanding shares of the company, which has a market capitalization of 599.21 million. As of now, sales total 573,280 K while income totals -33,540 K. Its latest quarter income was 138,650 K while its last quarter net income were 3,160 K.
